WJP
Luan D, Zhao MG, Shi YC, Li L, Cao YJ, Feng HX, Zhang ZJ. Mechanisms of repetitive transcranial
magnetic stimulation for anti-depression: Evidence from preclinical studies. World J Psychiatry 2020;
10: 223-233 [PMID: 33134113 DOI: 10.5498/wjp.v10.i10.223]
Landry M, Lafrenière S, Patry S, Potvin S, Lemasson M. The clinical relevance of dose titration in
electroconvulsive therapy: A systematic review of the literature. Psychiatry Res 2020; 294: 113497
[PMID: 33039882 DOI: 10.1016/j.psychres.2020.113497]
Guideline committee for affective disorders in the Japanese Society of Mood Disorders.
Treatment guideline for major depressive disorders by the Japanese Society of Mood Disorders.
Tokyo: Japanese Society of Mood Disorders, 2016. [cited 28 February 2021]. Available from:
https://www.secretariat.ne.jp/jsmd/iinkai/katsudou/data/20190724-02.pdf
American Psychiatric Association. American Psychiatric Association Practice Guidelines for the
Treatment of Psychiatric Disorders: Compendium 2006. Arlington: American Psychiatric Publishing,
Inc., 2006
Khalid N, Atkins M, Tredget J, Giles M, Champney-Smith K, Kirov G. The effectiveness of
electroconvulsive therapy in treatment-resistant depression: a naturalistic study. J ECT 2008; 24: 141145 [PMID: 18580559 DOI: 10.1097/YCT.0b013e318157ac58]
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a
systematic review and meta-analysis. Lancet 2003; 361: 799-808 [PMID: 12642045 DOI:
10.1016/S0140-6736(03)12705-5]
Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe
RR, Cooper TB, Prudic J. Continuation pharmacotherapy in the prevention of relapse following
electroconvulsive therapy: a randomized controlled trial. JAMA 2001; 285: 1299-1307 [PMID:
11255384 DOI: 10.1001/jama.285.10.1299]
Prudic J, Haskett RF, McCall WV, Isenberg K, Cooper T, Rosenquist PB, Mulsant BH, Sackeim HA.
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT 2013;
https://www.wjgnet.com
851
October 19, 2021
Volume 11
Issue 10
Kurimoto N et al. Diagnostic change for MDD after ECT
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
WJP
29: 3-12 [PMID: 23303417 DOI: 10.1097/YCT.0b013e31826ea8c4]
Serra M, Gastó C, Navarro V, Torres X, Blanch J, Masana G. [Maintenance electroconvulsive
therapy in elderly psychotic unipolar depression]. Med Clin (Barc) 2006; 126: 491-492 [PMID:
16624227 DOI: 10.1157/13086850]
Petrides G, Tobias KG, Kellner CH, Rudorfer MV. Continuation and maintenance electroconvulsive
therapy for mood disorders: review of the literature. Neuropsychobiology 2011; 64: 129-140 [PMID:
21811083 DOI: 10.1159/000328943]
Brown ED, Lee H, Scott D, Cummings GG. Efficacy of continuation/maintenance electroconvulsive
therapy for the prevention of recurrence of a major depressive episode in adults with unipolar
depression: a systematic review. J ECT 2014; 30: 195-202 [PMID: 24979654 DOI:
10.1097/YCT.0000000000000085]
Elias A, Phutane VH, Clarke S, Prudic J. Electroconvulsive therapy in the continuation and
maintenance treatment of depression: Systematic review and meta-analyses. Aust N Z J Psychiatry
2018; 52: 415-424 [PMID: 29256252 DOI: 10.1177/0004867417743343]
Ratheesh A, Davey C, Hetrick S, Alvarez-Jimenez M, Voutier C, Bechdolf A, McGorry PD, Scott J,
Berk M, Cotton SM. A systematic review and meta-analysis of prospective transition from major
depression to bipolar disorder. Acta Psychiatr Scand 2017; 135: 273-284 [PMID: 28097648 DOI:
10.1111/acps.12686]
Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, Warshaw M, Clayton P, Goodwin
F. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental
predictors in 559 patients. Arch Gen Psychiatry 1995; 52: 114-123 [DOI:
10.1001/archpsyc.1995.03950140032004]
Xiang YT, Zhang L, Wang G, Hu C, Ungvari GS, Dickerson FB, Kilbourne AM, Si TM, Fang YR,
Lu Z, Yang HC, Lai KY, Lee EH, Hu J, Chen ZY, Huang Y, Sun J, Wang XP, Li HC, Zhang JB, Chiu
HF. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major
depressive disorder in China. Bipolar Disord 2013; 15: 199-205 [PMID: 23437963 DOI:
10.1111/bdi.12052]
Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH; BRIDGE Study Group.
Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive
episode: the BRIDGE study. Arch Gen Psychiatry 2011; 68: 791-798 [PMID: 21810644 DOI:
10.1001/archgenpsychiatry.2011.87]
Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar
diathesis? J Affect Disord 2005; 84: 251-257 [PMID: 15708423 DOI: 10.1016/j.jad.2004.01.015]
Inoue T, Nakagawa S, Kitaichi Y, Izumi T, Tanaka T, Masui T, Kusumi I, Denda K, Koyama T.
Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity.
J Affect Disord 2006; 95: 61-67 [PMID: 16797078 DOI: 10.1016/j.jad.2006.04.020]
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.
Washington, DC: American Psychiatric Association, 1994
HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62
[PMID: 14399272 DOI: 10.1136/jnnp.23.1.56]
National Institute for Clinical Excellence. Guidance on the Use of Electroconvulsive Therapy.
Technology Appraisal Guidance 59. [cited 28 February 2021]. Available from:
https://www.nice.org.uk/guidance/ta59. 2003
Sackeim HA, Dillingham EM, Prudic J, Cooper T, McCall WV, Rosenquist P, Isenberg K, Garcia K,
Mulsant BH, Haskett RF. Effect of concomitant pharmacotherapy on electroconvulsive therapy
outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry 2009; 66: 729-737 [PMID:
19581564 DOI: 10.1001/archgenpsychiatry.2009.75]
Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M,
Bernstein HJ, O'Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson
S, Fink M. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in
major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy
(CORE). Arch Gen Psychiatry 2006; 63: 1337-1344 [PMID: 17146008 DOI:
10.1001/archpsyc.63.12.1337]
McInerney SJ, Kennedy SH. Review of evidence for use of antidepressants in bipolar depression.
Prim Care Companion CNS Disord 2014; 16 [PMID: 25667812 DOI: 10.4088/PCC.14r01653]
Bowden CL, Perlis RH, Thase ME, Ketter TA, Ostacher MM, Calabrese JR, Reilly-Harrington NA,
Gonzalez JM, Singh V, Nierenberg AA, Sachs GS. Aims and results of the NIMH systematic
treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci Ther 2012; 18: 243249 [PMID: 22070541 DOI: 10.1111/j.1755-5949.2011.00257.x]
Thomas RK, White PJ, Dursun S. Treating electroconvulsive therapy-induced mania with more
electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizer. SAGE
Open Med Case Rep 2018; 6: 2050313X18799236 [PMID: 30214809 DOI:
10.1177/2050313X18799236]
Lee J, Arcand L, Narang P, Lippmann S. ECT-induced Mania. Innov Clin Neurosci 2014; 11: 27-29
[PMID: 25621185]
Kessing LV, Willer I, Andersen PK, Bukh JD. Rate and predictors of conversion from unipolar to
bipolar disorder: A systematic review and meta-analysis. Bipolar Disord 2017; 19: 324-335 [PMID:
28714575 DOI: 10.1111/bdi.12513]
Farahani A, Correll CU. Are antipsychotics or antidepressants needed for psychotic depression? J
https://www.wjgnet.com
852
October 19, 2021
Volume 11
Issue 10
Kurimoto N et al. Diagnostic change for MDD after ECT
30
31
32
33
34
35
WJP
Clin Psychiatry 2012; 73: 486-496 [PMID: 22579147 DOI: 10.4088/JCP.11r07324]
Arandjelovic K, Eyre HA, Lavretsky H. Clinicians' Views on Treatment-Resistant Depression: 2016
Survey Reports. Am J Geriatr Psychiatry 2016; 24: 913-917 [PMID: 27591914 DOI:
10.1016/j.jagp.2016.05.010]
Itagaki K, Takebayashi M, Shibasaki C, Kajitani N, Abe H, Okada-Tsuchioka M, Yamawaki S.
Factors associated with relapse after a response to electroconvulsive therapy in unipolar vs bipolar
depression. J Affect Disord 2017; 208: 113-119 [DOI: 10.1016/j.jad.2016.08.047]
Sugawara H, Sakamoto K, Harada T, Ishigooka J. Predictors of efficacy in lithium augmentation for
treatment-resistant depression. J Affect Disord 2010; 125: 165-168 [PMID: 20089312 DOI:
10.1016/j.jad.2009.12.025]
First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I
Disorders SCID-I: Clinician Version, Administration Booklet. American Psychiatric Publishing, Inc.,
1997
Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, Lewis L, McElroy SL,
Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J. Development and validation of a screening
instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000;
157: 1873-1875 [PMID: 11058490 DOI: 10.1176/appi.ajp.157.11.1873]
Nassir Ghaemi S, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and
specificity of a new bipolar spectrum diagnostic scale. J Affect Disord 2005; 84: 273-277 [PMID:
15708426 DOI: 10.1016/S0165-0327(03)00196-4]
https://www.wjgnet.com
853
October 19, 2021
Volume 11
Issue 10
...
論文の公開元へ
